Drug intelligence / Profile preview

Protectival

Development stage
Unknown
Lead developer
LifeBiotic
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Protectival is a clinically researched botanical formulation developed by LifeBiotic, based on the LCS101 complex. It is designed for oncology supportive care to mitigate the side effects of conventional cancer treatments like chemotherapy and radiation. The formula is composed of extracts from 10 specific herbs, including *Astragalus membranaceus*, *Poria cocos*, and *Atractylodes macrocephala*. It functions through multi-pathway immune modulation, supporting healthy white and red blood cell levels, promoting cellular resilience, and improving the quality of life for patients undergoing oncology treatments. Clinical studies, including randomized controlled trials, have suggested its role in reducing hematological toxicity (such as anemia and neutropenia) and enhancing immune function without interfering with the efficacy of chemotherapy.

Brand names
Protectival
Other names
LCS101LCS-101LCS 101

Beyond the preview

Go deeper on Protectival.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protectival.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call